Trials / Completed
CompletedNCT03006198
Tracking Biologics Along the Silk Road
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 140 (actual)
- Sponsor
- Janssen Pharmaceutica N.V., Belgium · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to explore and describe the disease characteristics, treatment and outcomes of participants with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Crohn's Disease or ulcerative colitis as the major disease treated with REMICADE, SIMPONI or STELARA in clinical practice in the emerging regions of North Africa, the Middle East, and Western Asia.
Conditions
Timeline
- Start date
- 2016-02-04
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2016-12-30
- Last updated
- 2019-01-10
Locations
8 sites across 5 countries: Algeria, Egypt, Kuwait, Qatar, Saudi Arabia
Source: ClinicalTrials.gov record NCT03006198. Inclusion in this directory is not an endorsement.